Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruka Ikoma

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|December 27, 2019
18F-FDG Uptake of Localized Malignant Peritoneal MesotheliomaEriko Kodama, Toshiki Kodama, Tamaki Ichikawa, et al.
Clinical Case Reports|October 31, 2025
Abdominal Wall Schwannoma: A Rare Case of Target Sign on UltrasonographyNoboru Takanashi, Takayuki Tajima, Chieko Seto, et al.
Pathology International|October 11, 2022
The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP eraAtsushi Ito, Masashi Miyaoka, Sakura Tomita, et al.
Pathology International|November 2, 2021
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangementsMasashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2025
Redefining the Spectrum of Epstein-Barr Virus-Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin LymphomaShunsuke Nagase, Naoya Nakamura, Yara Yukie Kikuti, et al.
Cancers|August 14, 2025
Histological Image Classification Between Follicular Lymphoma and Reactive Lymphoid Tissue Using Deep Learning and Explainable Artificial Intelligence (XAI)Joaquim Carreras, Haruka Ikoma, Yara Yukie Kikuti, et al.
Pathology International|March 17, 2022
Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangementsHaruka Ikoma, Masashi Miyaoka, Shinichiro Hiraiwa, et al.
Pathology International|July 5, 2026
AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With Double-Hit MYC and BCL2 or BCL6 and Triple HitMasashi Miyaoka, Joaquim Carreras, Yara Yukie Kikuti, et al.
Cancers|December 11, 2022
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster AmplificationMasashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, et al.
The Tokai Journal of Experimental and Clinical Medicine|August 27, 2023
Nodular Pulmonary Amyloidosis Preceding Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Initially Suspected to Be Lung CancerNaokata Kutsuzawa, Hiroto Takiguchi, Haruka Ikoma, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|December 27, 2019
18F-FDG Uptake of Localized Malignant Peritoneal MesotheliomaEriko Kodama, Toshiki Kodama, Tamaki Ichikawa, et al.
Clinical Case Reports|October 31, 2025
Abdominal Wall Schwannoma: A Rare Case of Target Sign on UltrasonographyNoboru Takanashi, Takayuki Tajima, Chieko Seto, et al.
Pathology International|October 11, 2022
The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP eraAtsushi Ito, Masashi Miyaoka, Sakura Tomita, et al.
Pathology International|November 2, 2021
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangementsMasashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2025
Redefining the Spectrum of Epstein-Barr Virus-Positive (EBV+) Diffuse Large B-cell Lymphoma and EBV+ Classic Hodgkin LymphomaShunsuke Nagase, Naoya Nakamura, Yara Yukie Kikuti, et al.
Cancers|August 14, 2025
Histological Image Classification Between Follicular Lymphoma and Reactive Lymphoid Tissue Using Deep Learning and Explainable Artificial Intelligence (XAI)Joaquim Carreras, Haruka Ikoma, Yara Yukie Kikuti, et al.
Pathology International|March 17, 2022
Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangementsHaruka Ikoma, Masashi Miyaoka, Shinichiro Hiraiwa, et al.
Pathology International|July 5, 2026
AID and MUM1 Negativity Identifies a Prognostically Favorable Subgroup of Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With Double-Hit MYC and BCL2 or BCL6 and Triple HitMasashi Miyaoka, Joaquim Carreras, Yara Yukie Kikuti, et al.
Cancers|December 11, 2022
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster AmplificationMasashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, et al.
The Tokai Journal of Experimental and Clinical Medicine|August 27, 2023
Nodular Pulmonary Amyloidosis Preceding Gastric Mucosa-associated Lymphoid Tissue Lymphoma, Initially Suspected to Be Lung CancerNaokata Kutsuzawa, Hiroto Takiguchi, Haruka Ikoma, et al.
Pageof 3